Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: Department of Health (Therapeutic Goods Administration)
Juno Pharmaceuticals Pty Ltd
Class III
IBSA Farmaceutici Italia Srl Via Martiri di Cefalonia 2, Lodi, 26900 Italy
44670 - Bladder instillation, barrier
Procedure pack consisting of a clear plastic pre-filled syringe containing a sterile aqueous solution of hyaluronic acid sodium salt (1.6%), sodium chondroitin sulphate (2%) and calcium chloride administered as a bladder instillation via connection to a catheter using the leur lock adaptor and the iAluAdapter included in the pack. The iAluAdapter allows for administration by either the patient or healthcare professional. iAluRil is indicated to re-establish the glycosaminoglycan layers (GAGs) of the urothelial vesical tissue in cases in which their loss can cause frequent and recurring problems such as Painful Bladder Syndrome (PBS), interstitial cystitis, treatment and prevention of recurrent urinary tract infection, cystitis as a result of Bacillus Calmette ? Guerin therapy, or chemical and radiation therapy. iAluRil is also indicated in the cases where the loss of the glycosaminoglycan layers (GAGs) is associated with forms of chronic inflammation, in which their composition and integrity appears compromised in different ways.
A
2015-02-10